Purpose: To report the clinical features and outcome of patients with prima
ry adenocarcinoma of the anus following radiotherapy with or without chemot
herapy,
Methods and Materials: A retrospective analysis was performed on 15 patient
s referred to Peter MacCallum Cancer Institute between 1981 to 1998 with pr
imary adenocarcinoma of the anus. The median follow-up was 7.5 years. Six p
atients underwent treatment with curative intent-either chemoradiation or r
adiotherapy alone. Surgery,vas mainly limited to either incisional or excis
ional biopsy. The remaining nine patients were treated with palliative inte
nt because of advanced age; advanced disease, or poor medical status. The b
iological equivalent doses were calculated for all patients and correlated
with time to progression.
Results: None of the curative group had relapsed after a median follow-up o
f 6.6 years. All except one were alive and well, No patient developed any s
erious long-term toxicity and all patients avoided colostomy, All patients
managed with palliative intent died with persistent locoregional disease wi
th a median survival of 0.8 year,
Conclusion: Primary adenocarcinoma of the anus is a very rare disease that
precludes a rigorous analysis, This study demonstrates that radiation and i
n particular chemoradiation are effective therapies consistent with other r
ecent series and analogous to squamous cell carcinomas of the anus, It also
emphasizes the poor prognosis of patients treated with palliative intent.
(C) 1999 Elsevier Science Inc.